Literature DB >> 8183494

Severe vitamin D deficiency in Auckland.

N McGrath1, V Singh, T Cundy.   

Abstract

AIMS: To study the presentation of severe vitamin D deficiency in Auckland and to determine if appropriate therapy was given.
METHODS: Retrospective review of records of patients with very low plasma 25 hydroxyvitamin D concentrations (< or = 12.5 nmol/L or 5 micrograms/L).
RESULTS: Fifty cases were identified over a two year period. 28 subjects had recognised risk factors for vitamin D deficiency (such as gastrointestinal disease or greatly reduced food intake). The majority of the other 22 subjects were elderly residents of rest homes or private hospitals. Low body weight and reduced mobility were common features of both groups. Increased plasma alkaline phosphatase activity and hypocalcaemia were the most frequent biochemical findings. Appropriate treatment with high dose calciferol had been given to only 28% of the subjects.
CONCLUSIONS: Severe vitamin D deficiency does occur in Auckland despite its low latitude. Low body weight, reduced mobility and lack of sun exposure are particular risk factors. Appropriate therapy is cheap, safe and effective but many patients with severe vitamin D deficiency are being managed suboptimally.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8183494

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  2 in total

1.  Hyperparathyroidism secondary to hypovitaminosis D in hypoalbuminemic is less intense than in normoalbuminemic patients: a prevalence study in medical inpatients in southern Brazil.

Authors:  Melissa Orlandin Premaor; Gustavo Vasconcelos Alves; Ligia Beatriz Crossetti; Tania Weber Furlanetto
Journal:  Endocrine       Date:  2004-06       Impact factor: 3.633

2.  The effect of a single dose versus a daily dose of cholecalciferol on the serum 25-hydroxycholecalciferol and parathyroid hormone levels in the elderly with secondary hyperparathyroidism living in a low-income housing unit.

Authors:  Melissa O Premaor; Rosana Scalco; Marília J S da Silva; Pedro E Froehlich; Tania W Furlanetto
Journal:  J Bone Miner Metab       Date:  2008-11-01       Impact factor: 2.626

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.